223463-13-6 5-Bromo-2-iodopyridine 99%
Price | Get Latest Price | ||||
Packge | 1MT | 1kg | 5kg | 10kg | 25kg |
- Min. Order:1MT
- Time:2023-06-06
Product Details
- Product Name5-Bromo-2-iodopyridine
- CAS No.223463-13-6
- EINECS No.606-990-6
- MFC5H3BrIN
- MW283.89
- InChIKeyHSNBRDZXJMPDGH-UHFFFAOYSA-N
- AppearanceCrystalline PowderWhite to beige
- Melting point 113-117 °C (lit.)
- Boiling point 258.8±20.0 °C(Predicted)
- density 2.347±0.06 g/cm3(Predicted)
- storage temp. Keep in dark place,Sealed in dry,Room Temperature
Company Profile Introduction
Altrakem Pharma Lifesciences Pvt. Ltd. is a Hyderabad, India based company with a primary focus on offering chemistry services to pharmaceutical companies, biotech entities, academics, biomaterials, and catalysts industry. Altrakem offers custom synthesis, Pyridine Derivatives, Fine chemicals, Speciality chemicals Process Development for API Intermediates, Custom Synthesis of Pyridine Derivatives building blocks &Speciality chemicals , Large scale contract Manufacturing under GMP / Non GMP.
Supplier other products
Recommended supplier
-
VIP1年
- Innovative Labs
- 5-Bromo-2-iodopyridine 223463-13-6 98%
- Inquiry
- 2024-02-15
-
VIP1年
- Jubilant Ingrevia
- 5-Bromo-2-iodopyridine 98%
- Inquiry
- 2024-02-08
-
VIP1年
- Dr R R Organics
- 223463-13-6 98%
- Inquiry
- 2024-02-07
-
VIP1年
- Sintilla Medcoms Pvt Ltd
- 5-Bromo-2-iodopyridine 98%
- Inquiry
- 2024-01-11
-
VIP1年
- REDDY N REDDY PHARMACEUTICALS
- 5-BROMO-2-IODO PYRIDINE 223463-13-6 98%
- Inquiry
- 2023-11-22
-
VIP1年
- VGS SYNTHESIS PRIVATE LIMITED
- 2-Iodo-5-bromo pyridine 98%
- Inquiry
- 2023-11-21
-
VIP1年
- CHATURYA BIOTECH
- 223463-13-6 99%
- Inquiry
- 2023-10-26
-
VIP1年
- SVH BIOSCIENCES
- 223463-13-6 5-Bromo-2-iodo pyridine 99%
- Inquiry
- 2023-09-27
-
VIP1年
- Varna Chems
- 5-Bromo-2-iodopyridine 223463-13-6 99%
- Inquiry
- 2023-09-25
-
VIP1年
- SRIWEN LABS
- 5-Bromo-2-iodo pyridine 98%
- Inquiry
- 2023-09-15
- Since:2023-05-18
- Address: Plot No. 5, Road No-15 CFC Area, IDA-Nacharam, Hyderabad, Telangana-500 076, India
INQUIRY